Established · publishing since 1989Rising activity
Bone health and treatmentsBone Metabolism and DiseasesProstate Cancer Treatment and ResearchBone health and osteoporosis researchBone and Joint Diseases
Publications
280
Citations
21,247
Est. group size
~9
Recurring co-author estimate
Active years
37
Publishing since 1989
In context
Among 4,953 established Medicine PIs within our index
Citations: 21,247p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 11.6p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~7 · 23% small-team papers (≤3 authors) · across 28 venues
Publication cadence
Publications per year over the last 10 years — averaging 11.6/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- The Power of Gies, Science, and the University: The 100th Anniversary of the Gies Report Research and Its Impact on the Dental Profession
Journal of Dental Education · 2025
- Efferocytosis and Bone Dynamics
Current Osteoporosis Reports · 2024
- Abstract 5538: Efferocytosis-induced HIF-1α enhances tumor vascularization and promotes osteoblastic bone remodeling in metastatic prostate cancer
Cancer Research · 2024
- The Role of Tumor Epithelial-Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression
Current Osteoporosis Reports · 2023
- Parathyroid hormone and trabectedin have differing effects on macrophages and stress fracture repair
Bone · 2023
- Supplementary Figures 1-3 from A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
2023
- Data from A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
2023
- Supplementary Figures 1-3 from A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
2023
- Supplementary Figure Legend from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Figure 4 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Table 1 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Figure 2 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Figure 1 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Figure 5 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
- Supplementary Figure 3 from Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone
2023
Publishes in
- Current Osteoporosis Reports×4
- Journal of Bone and Mineral Research×3
- Cancer Research×3
- Journal of Cellular Biochemistry×2
- Journal of Dental Research×2
Similar researchers
By research-topic overlap
- Gregory A. Clines
Medicine · University of Michigan
- Amy J. Koh
Medicine · University of Michigan
- Stewart A. Low
Medicine · Purdue University West Lafayette
- Joy Y. Wu
Medicine · Purdue University West Lafayette
- Matthew Smith
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile